Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: The influence of familial essential hypertension

Kidney and Blood Pressure Research

Volumn 32, Issue 4, 2009, Pages 258-262

  Monthe Kontchou, Laure ^a   Liccioli, Giulia ^a   Pela, Ivana ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Blood pressure; Children; Essential hypertension; Nephrotic syndrome; Steroid therapy

Indexed keywords

PREDNISONE;

ARTICLE; BLOOD PRESSURE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; HUMAN; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEROID THERAPY;

ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; EDEMA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; STEROIDS;

EID: 70049105905     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000238823     Document Type: Article

References (25)

1. Niaudet P: Steroid-sensitive idiopathic nephritic syndrome in children; in Avner ED, Harmon WE, Niaudet P (eds): Pediatric Nephrology, ed 5. Philadelphia, Lippincott Williams & Wilkins, 2004, chapt 27, pp 543- 556.
2. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981; 98: 561-564.
3. Hodson E, Willis NS, Craig JC: Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2007; 4: CD001533.
4. Kuster S, Melhs O, Seidel C, Ritz E: Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol 1990; 10(suppl 1):76-80.
5. Tabel Y, Mungan I, Karakurt C, Kocak G, Gungor S: Is edema in minimal change disease of childhood really hypovolemic? Int Urol Nephrol 2008; 40: 757-761.
6. Staessen JA, Wang J, Bianchi G, Birkenhager WH: Essential hypertension. Lancet 2003; 361: 1629-1641.
7. Ward R: Familial aggregation and genetic epidemiology of blood pressure; in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management. New York, Raven Press, 1990, pp 81-89.
8. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.
9. Woolfson RG, de Waardner HE: Primary renal abnormalities in hereditary hypertension. Kidney Int 1996; 50: 717-731.
10. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114(2 Suppl):555-576.
11. Weder AB: Genetics and hypertension. J Clin Hypertens 2007; 9: 217-223.
12. Izawa H: Prediction of genetic risk for hypertension. J Clin Hypertens 2003; 41: 1035-1040.
13. Yamada Y: Assessment of the genetic component of hypertension. Am J Hypertens 2006; 19: 1158-1165.
14. van Rijn MJE, Schut AFC, Aulchenko YS, Deinum J, Sayed-Tabatabaei FA, Yazdanpanah M, Isaacs A, Axenovich T, Zorkoltseva IV, Zillikens MC, Pols H, Witteman JCM, Oostra BA, van Duijn CM: Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related-genes. J Hypertens 2007; 25: 565-570.
15. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA: Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 2005; 85: 679-715.
16. Stamler J: The INTERSALT study: background, methods, findings, and implications. Am J Clin Nutr 1997; 65(2 suppl)626S- 642S.
17. Vehaskari VM: Heritable forms of hypertension. Pediatr Nephrol 2007 DOI: 10.1007/ s00467-007-0537-538
18. Bernstein D: The cardiovascular system in systemic hypertension; in Behrman ER, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics, ed 17. Philadelphia, Saunders Company, 2004, pp 1592-1598.
19. Koomans HA: Pathophysiology of oedema in idiopathic nephrotic syndrome. Nephrol Dial Transplant 2003; 18(suppl 6):vi30-vi32.
20. Vande Walle JG, Donckerwolcke RAMG, Van Isselt JW, Derkx FHM, Joles JA, Koomans HA: Volume regulation in children with early relapse of minimal change nephrosis with or without hypovolaemic symptoms. Lancet 1995; 346: 148-152.
21. Mantero F, Boscaro M: Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 1992; 43: 409-413.
22. Whitworth JA, Brown MA, Kelly JJ, Williamson PM: Mechanisms of cortisol-induced hypertension in humans. Steroids 1995; 60: 76-80.
23. Donckerwolcke RAMG, France A, Raes A, Vande Walle J: Distal nephron sodium-potassium exchange in children with nephrotic syndrome. Clin Nephrol 2003; 59: 259-266.
24. Vande Walle JG, Donckerwolcke RAMG, Van Isselt JW, Derkx FHM, Joles JA, Koomans HA: Volume regulation in children with early relapse of minimal change nephrosis with or without hypovolaemic symptoms. Lancet 1995; 346: 148-152.
25. Vande Walle JG, Donckerwolcke RAMG, Koomans HA: Pathophysiology of oedema formation in children with histological lesions compared with minimal lesions nephrotic syndrome. J Am Soc Nephrol 1999; 10: 313-323.